Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Jun 27, 2012 yancopoulos george Officer Acquisition (Non Open Market) 500,000 n/a
Jun 19, 2012 stahl neil Officer Automatic Sell 38,911 115.60 - 118.10
Jun 18, 2012 stahl neil Officer Automatic Sell 56,168 115.29
Jun 18, 2012 stahl neil Officer Option Execute 95,079 20.32
May 31, 2012 sing george l Director Sell 5,000 134.74 - 135.15
May 30, 2012 sing george l Director Sell 5,000 134.00
May 24, 2012 aberman michael s Officer Option Execute 500 24.00
May 21, 2012 goldberg murray a Officer Option Execute 16,244 11.64 - 21.92
May 21, 2012 shooter eric m Director Sell 18,000 123.23 - 124.07
May 21, 2012 shooter eric m Director Option Execute 18,000 18.61 - 24.41
May 18, 2012 shooter eric m Director Sell 2,000 124.04
May 18, 2012 shooter eric m Director Option Execute 2,000 18.61
May 10, 2012 ryan arthur f Director Disposition (Non Open Market) 7,000 n/a
May 3, 2012 goldberg murray a Officer Automatic Sell 24,642 132.96 - 138.48
May 2, 2012 goldberg murray a Officer Automatic Sell 36,741 134.64 - 138.28
May 2, 2012 goldberg murray a Officer Option Execute 54,438 21.92
May 1, 2012 aberman michael s Officer Automatic Sell 6,162 134.52 - 135.29
May 1, 2012 schleifer leonard s Officer Automatic Sell 100,000 133.86 - 136.57
May 1, 2012 yancopoulos george Officer Automatic Sell 33,165 133.95 - 135.29
Showing 401-420 of 850 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)